Betaklinik, Bonn, Germany.
Department of Therapeutic and Interventional Cardiology Preventive Medicine, Beta Clinic, The International Hospital, Joseph - Schumpeter - Allee 15, 53227, Bonn, Germany.
BMC Cardiovasc Disord. 2024 Oct 17;24(1):572. doi: 10.1186/s12872-024-04245-8.
In Germany, contemporary data on the prevalence of patients with an implantable cardioverter-defibrillator (ICD) is lacking. Recently, ICD patients with heart failure (HF) fulfilling pre-defined criteria by the G-BA (Federal Joined Committee) are eligible for remote monitoring (RM) reimbursement. This investigation aims to evaluate the prevalence of HF patients with an ICD meeting these criteria.
Annual national quality assurance data from all German hospitals on newly implanted ICDs, New York Heart Association (NYHA) class and left ventricular ejection fraction (LVEF) between 2010 and 2021 were obtained to build a prevalence model. The number of ICD patients eligible for RM was calculated by applying the main G-BA inclusion criteria.
The ICD prevalence increased continuously from 2010 to 2017 (202.637 patients in 2017) and decreased with a lower rate until 2022. The model calculated an ICD prevalence of 190.698 patients in 2022 of which an estimated 120.941 ICD patients with HF were eligible for RM. This reflects approximately 63% of the actual total estimated ICD patient population in Germany.
The model identified a large patient population currently eligible for RM. To our knowledge, this is the first study providing information on the size of this ICD patient population with HF in Germany. With only a fraction of eligible patients currently receiving RM, these findings may facilitate future planning, resource calculations and scale-up of RM. The building of a specific infrastructure focussing on efficient use of resources reflects a mandatory prerequisite for successful RM implementation.
德国缺乏有关植入式心脏复律除颤器 (ICD) 患者患病率的最新数据。最近，符合联邦联合委员会 (G-BA) 预先定义标准的心力衰竭 (HF) ICD 患者有资格获得远程监测 (RM) 报销。本研究旨在评估符合这些标准的 HF ICD 患者的患病率。
从 2010 年至 2021 年，从德国所有医院的年度国家质量保证数据中获取新植入 ICD 的年度数据、纽约心脏协会 (NYHA) 分级和左心室射血分数 (LVEF)，以建立患病率模型。通过应用 G-BA 的主要纳入标准，计算出符合 RM 条件的 ICD 患者数量。
ICD 的患病率从 2010 年持续增加到 2017 年（2017 年为 202.637 例），然后以较低的速度下降，直到 2022 年。该模型计算出 2022 年 ICD 的患病率为 190.698 例，其中估计有 120.941 例 HF ICD 患者有资格进行 RM。这反映了德国实际 ICD 患者总数的约 63%。
该模型确定了目前有资格接受 RM 的大量患者群体。据我们所知，这是第一项提供德国 HF ICD 患者规模信息的研究。由于只有一小部分符合条件的患者目前正在接受 RM，这些发现可能有助于未来的规划、资源计算和 RM 的扩展。建立一个专注于高效利用资源的特定基础设施反映了成功实施 RM 的必要前提。
